Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing surveillance of DIACOMIT (stiripentol) in Japan
jRCT1080225085Completed
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of stiripentol in epilepsy, sponsored by Meiji Seika Pharma Co., Ltd. Started Feb 2020; status: completed.
02
Drugs
stiripentol
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT1080225085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225085.